Type 1 diabetes is an autoimmune disease in which the immune system attacks insulin-producing pancreatic cells. A positive autoantibody screen alone does not establish diagnosis.

Conceptual illustration of the relationship between pancreatic beta cells and immune activity

1. Beta cells and the role of insulin

Pancreatic beta cells make insulin, a hormone that helps glucose in the blood enter the body’s cells to be used for energy. In type 1 diabetes, these insulin-producing cells are damaged and the body makes too little insulin. NIDDK and the American Diabetes Association (ADA) describe this basic physiology in their patient guidance.

2. What an islet autoantibody test can tell you

A health professional may use a blood test for certain autoantibodies to help identify type 1 diabetes. NIDDK explains that autoantibodies are immune proteins that mistakenly attack healthy tissue, and that their presence may indicate type 1 diabetes. The ADA adds an essential limit: a positive islet autoantibody screening result alone does not mean that a person has type 1 diabetes. Counseling and additional testing may be needed.

3. Glucose and autoantibody tests answer different questions

Glucose tests help establish whether diabetes is present; NIDDK notes that the usual diagnostic tests may not determine its type. An autoantibody test looks for markers of an immune response and may help clarify type or assess risk. A positive screening result alone does not diagnose type 1 diabetes, so the purpose and meaning of each test need to be considered separately.

4. 2024 consensus: confirm a positive result and distinguish antibody counts

An international expert consensus published in 2024 recommends confirming an initial positive islet autoantibody result with a second test, preferably within three months. Accuracy can vary by laboratory and target antigen, so confirmation helps establish whether positivity persists. The consensus distinguishes a single positive autoantibody from persistent positivity for multiple autoantibodies. Multiple confirmed antibodies with normal glucose can meet criteria for stage 1 type 1 diabetes; a single or transient single result does not represent the same stage. This is a distinction for classification and follow-up, not a promise about when an individual will develop clinical diabetes.

Confirmed multiple-autoantibody status also means that two different antibodies are found across two separate samples. A single test showing several markers is therefore not the same as persistent multiple positivity.

5. Monitoring covers glucose, symptoms and support

The 2024 consensus calls for interpreting confirmed antibodies alongside glucose and cooperation between endocrinology and primary care. Multiple antibodies with normal glucose indicate stage 1; multiple antibodies with dysglycemia before clinical diabetes criteria indicate stage 2. These are early stages of type 1 diabetes, not merely a risk of having the condition in the future. The care team chooses tests, timing and treatment discussions. Education and psychosocial support are included, with the limitation that much evidence comes from research programs. Monitoring cannot guarantee prevention of progression or emergencies.

6. A record and questions after a positive screen

Record “sample date / result for each named antibody and laboratory / initial or confirmation sample / glucose assessment and clinician’s interpretation / contact clinic / next confirmation plan.” A fictional entry, “16 October, antibody A positive, other antibodies and glucose assessment unconfirmed, confirmation consultation pending,” does not demonstrate persistent multiple antibodies or establish a stage. Ask whether confirmation is needed, who will review antibody and glucose findings together, and which symptoms require contacting whom. Waiting for confirmation must not delay assessment of new symptoms.

NIDDK describes breathing difficulty, fruity-smelling breath, vomiting/abdominal pain or fainting from dehydration among possible DKA symptoms. Suspected emergency symptoms require immediate emergency care, not waiting for a routine confirmation test. The record does not direct insulin initiation, stopping or dosing.

Sources